Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa

Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) patients receiving ethambutol, cycloserine, or terizidone as part of a standardized regimen were compared, determining occurrence of serious adverse drug events (SADEs). Newly diagnosed adult MDR-TB patients were enrolled between 200...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Antimicrob Agents Chemother
Główni autorzy: van der Walt, Martha L., Shean, Karen, Becker, Piet, Keddy, Karen H., Lancaster, Joey
Format: Artigo
Język:Inglês
Wydane: American Society for Microbiology 2020
Hasła przedmiotowe:
Clinical Therapeutics
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7927816/
https://ncbi.nlm.nih.gov/pubmed/33046491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00744-20
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy